Simone Brogi

Attività didattica

Incarichi di responsabilità didattica di moduli/insegnamenti

Registro lezioni

Orario lezioni

Pubblicazioni

• Selaginella bryopteris-derived silver nanoparticles against ovarian cancer cells: green synthesis, in vitro anticancer activity, and exploratory in silico analysis (Dey, S.; Wadhwa, K.; Kumari, N.; Pandey, C.; Kumar, A.; Calderone, V.; Brogi, S.; Kapoor, N. - 2026 - 1.1 Articolo in rivista)
• Novel benzofuran–1,3,4-thiadiazole aryl urea hybrids as dual VEGFR-2/BRAF inhibitors: anticancer activity, apoptosis induction, and molecular modeling studies (Serag, M. I.; Elnagar, M. R.; Ewes, W. A.; Abdel-Aziz, A. A. -M.; Brogi, S.; Ghabbour, H. A.; Takla, F. N.; Hamdi, A.; El-Shafey, H. W.; El-Azab, A. S. - 2026 - 1.1 Articolo in rivista)
• Taginostat, a new quinolone-based HDAC6 inhibitor, promotes apoptosis of chronic lymphocytic leukemia cells in vitro and in vivo by activating STAT4 (Tatangelo, V.; Carullo, G.; Lopresti, L.; Ulivieri, C.; Brogi, S.; Butini, S.; Gatta, M.; Capitani, N.; Rungo, F.; Cavallo, M. C.; Gozzetti, A.; Bocchia, M.; Tozzi, M.; Ciofini, S.; Gemma, S.; Baldari, C. T.; Campiani, G.; Patrussi, L. - 2026 - 1.1 Articolo in rivista)
• Integrated structure-based and fragment-guided design of isonicotinic acid derivatives as potential KDM4A inhibitors: an insilico study (Eslami, K.; Sirous, H.; Cursaro, I.; Milioni, L.; Shafiee, F.; Carullo, G.; Gemma, S.; Rajabi, S.; Campiani, G.; Calderone, V.; Brogi, S. - 2026 - 1.1 Articolo in rivista)
• Thiazolidinedione-triazole hybrids: design, synthesis, and biological evaluation as dual inhibitors of a-amylase and aldose reductase with antioxidant activity for antidiabetic therapy (Nasr, E. E.; Elnagar, M. R.; El-Sayed, N. N. E.; Serag, M. I.; Elbadawi, M. M.; El-Azab, A. S.; Brogi, S.; Ghabbour, H. A.; Hamdi, A.; Abdel-Aziz, A. A. -M. - 2026 - 1.1 Articolo in rivista)
• Discovery of thieno[2,3-d]pyrimidine-based dual Aurora B/VEGFR-2 inhibitors with potent anticancer activity: molecular docking, mechanistic studies, and in vivo validation in a breast cancer model (El-Shafey, H. W.; Hamdi, A.; Elnagar, M. R.; Gebril, S. M.; Haikal, A.; El-Azab, A. S.; Brogi, S.; Al-Suwaidan, I. A.; Abdel-Aziz, A. A. -M. - 2026 - 1.1 Articolo in rivista)
• Quinazoline-sulfonamide hybrids as multitarget anticancer agents: inhibition of carbonic anhydrase IX/XII isoforms and VEGFR-2 with in vitro and in silico validation (Zeidan, M. A.; Al-Sanea, M. M.; Elnagar, M. R.; Tawfik, M. M.; El-Shafey, H. W.; Tawfik, S. S.; Brogi, S.; Hamdi, A. - 2026 - 1.1 Articolo in rivista)
• 2-Phenylquinolines Exhibit Anti-Severe Acute Respiratory Syndrome Coronavirus-2 Activity Through the Nonstructural Protein 13 Helicase Inhibition (Cernicchi, G.; Nizi, M. G.; Emmolo, R.; Persoons, L.; Laporte, M.; Jochmans, D.; Romeo, I.; Pepe, G.; Milite, C.; Campiglia, P.; Spezzini, J.; Martelli, A.; Brogi, S.; Esposito, F.; Felicetti, T.; Massari, S.; Manfroni, G.; Sabatini, S.; Sbardella, G.; Alcaro, S.; Neyts, J.; Corona, A.; Tramontano, E.; De Jonghe, S.; Tabarrini, O. - 2026 - 1.1 Articolo in rivista)
• Dimeric Anthraquinone Rugulosin A Induces Apoptosis in Lung Adenocarcinoma and Targets PI3K/AKT/MAPK Pathways In Silico (Manzano, J. A. H.; Abellanosa, E. A. M.; Aguilar, J. P. P.; Brogi, S.; Yen, C. -H.; Notarte, K. I.; Austriaco, N.; Macabeo, A. P. G. - 2026 - 1.1 Articolo in rivista)
• Second-generation prokineticin PKR1 receptor agonists: Advancing cardioprotection against chemotherapy-induced toxicity (Audebrand, A.; Brogi, S.; Tezeren, M.; Tafi, A.; Ocak, O. H.; Koyuncu, H.; Tetko, I.; Desaubry, L.; Nebigil, C. G. - 2026 - 1.1 Articolo in rivista)
• Quinazolinone-Based PqsR Modulators Suppress Quorum-Sensing–Driven Virulence in Pseudomonas aeruginosa (Tudino, V.; Mellini, M.; Milioni, L.; Carullo, G.; Rossi, S.; Giammarino, F. M. P. R.; Butini, S.; Brogi, S.; Ciccone, V.; Visca, P.; Leoni, L.; Rampioni, G.; Gemma, S.; Campiani, G. - 2026 - 1.1 Articolo in rivista)
• Targeting Class I Histone Deacetylases Triggers Antitumor Responses in Colorectal Cancer In Vitro and In Vivo (Carullo, G.; Falbo, F.; Tudino, V.; Song, J.; Fava, M.; Fontana, A.; Koch, A.; Heiss, A.; Erlenbach-Wuensch, K.; Panzeca, G.; Brogi, S.; Bichicchi, A.; Saponara, S.; Fusi, F.; Vincenzi, F.; Varani, K.; Cappello, M.; Pasquini, S.; Ramunno, A.; Pepe, G.; Butini, S.; Aiello, F.; Gemma, S.; Schneider-Stock, R.; Campiani, G. - 2026 - 1.1 Articolo in rivista)
• In Silico Exploration of Potential Inhibitors Targeting SARS-CoV-2 Non-Structural Protein 15 [Nsp15]: A Comprehensive Overview of Current Research (Yazdani, B.; Sirous, H.; Farzam, F.; Ansarizadeh, S.; Karimi Taheri, M.; Pourmohammad-Hosseini, G.; Noei, M.; Daneshipour, K.; Shakeri, D.; Houshangi, M.; Calderone, V.; Brogi, S. - 2025 - 1.1 Articolo in rivista)
• Exploiting COX-2 engagement for amplifying anticancer potential of Quinazoline-triazole conjugates with superior EGFR/VEGFR-2 inhibition (Serag, M. I.; Hamdi, A.; Nasr, E. E.; Elnagar, M. R.; Tawfik, M. M.; El-Azab, A. S.; Brogi, S.; Al-Suwaidan, I. A.; Hefnawy, M.; Abdel-Aziz, A. A. -M. - 2025 - 1.1 Articolo in rivista)
• Pharmacological Investigation of a Novel Resveratrol-like SIRT1 Activator Endowed with a Cardioprotective Profile (Carbonetti, Leonardo; Brogi, Simone; D'Orsi, Rosarita; Lessi, Marco; Calderone, Vincenzo; Testai, Lara; Bellina, Fabio - 2025 - 1.1 Articolo in rivista)

Tutte le pubblicazioni di Simone Brogi su ARPI, l'archivio della Ricerca dell'Università di Pisa